VVOS
vs
C
CGN
VVOS
Over the past 12 months, VVOS has underperformed CGN, delivering a return of -63% compared to the CGN's 15% drop.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
VVOS
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Vivos Therapeutics Inc
NASDAQ:VVOS
|
1.75
USD
|
|||||
|
C
|
Cigna Group
XMUN:CGN
|
237.75
EUR
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
VVOS, CGN
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
|
Vivos Therapeutics Inc
Revenue
|
|||||||||||
|
C
|
Cigna Group
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
VVOS, CGN
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
|
Vivos Therapeutics Inc
NASDAQ:VVOS
|
|||||||||
|
C
|
Cigna Group
XMUN:CGN
|
|||||||||
Compare company's free cash flow with its competitors.
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Vivos Therapeutics Inc | ||||
|
C
|
Cigna Group | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
VVOS, CGN
Performance Gap
VVOS, CGN
Performance By Year
VVOS, CGN
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
